The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 3917-3924

  Evans, Susan ^a   Dizeyi, Nishtman ^a   Abrahamsson, Per Anders ^a   Persson, Jenny ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cancer metastasis; Cancer treatment; Hormone refractory prostate cancer; Natural botanical components; TBS 101

Indexed keywords

CHAMOMILE; CRANBERRY EXTRACT; ETOPOSIDE; GANODERMA LUCIDUM EXTRACT; GINSENG EXTRACT; GRAPE SEED EXTRACT; GREEN TEA EXTRACT; TBS 101; UNCLASSIFIED DRUG; VITIS VINIFERA EXTRACT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IC 50; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHAMOMILE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; GANODERMA; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS; VACCINIUM MACROCARPON; VITIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 71949122373     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Yin M, Bastacky S, Chandran U, Becich MJ and Dhir R: Prevalence of incidental prostate cancer in the general population: A study of healthy organ donors. Urology 179: 892-895, 2008.
3. Grönberg H: Prostate cancer epidemiology. Lancet 361: 859-864, 2003.
4. Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003.
5. Albertsen PC, Hanley JA and Fine J: 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293: 2095-2101, 2005. (Pubitemid 40617061)
6. American Cancer Society: Cancer facts and figures 2008. American Cancer Society: Atlanta, GA. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured. pdf (accessed 12 Dec 2008).
7. DeMarzo AM, Nelson WG, Isaacs WB and Epstein JI: Pathological and molecular aspects of prostate cancer. Lancet (British edition) 361: 955-964, 2003. (Pubitemid 36332115)
8. Di Lorenzo G, Figg WD, Fossa SD, Mirone V, Autorino R and Longo N: Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study. Euro Urol 54: 1089-1096, 2008.
9. Friberg LE, Henningsson A, Maas H, Nguyen L and Karlsson MO: Model of chemotherapy-induced myelosuppression with parameter consistency across drugs. J Clin Oncol 20: 4713-4721, 2002. (Pubitemid 36025290)
10. Helms S: Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 9: 259-274, 2004.
11. Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA et al: Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res 67: 8396-8405, 2007.
12. Raina K, Singh RP, Agarwal R and Agarwal C: Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Cancer Res 67: 5976-5982, 2007. (Pubitemid 46985034)
13. Neto CC, Amoroso JW and Liberty AM: Anticancer activities of cranberry phytochemicals: an update. Mol Nutr Food Res 52(Suppl 1): S18-27, 2008.
14. Zaidman BZ, Wasser SP, Nevo E and Mahajna J: Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Int J Oncol 31: 959-967, 2007.
15. Srivastava JK, Gupta S: Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J Agric Food Chem 55: 9470-9478, 2007.
16. Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH et al: Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Nutr Cancer 60: 483-491, 2008. (Pubitemid 351918537)
17. Aalinkeel R, Bindukumar B, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC et al: The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat-shock protein 90. Prostate 68: 1773-1789, 2008.
18. Gupta S: Prostate cancer chemoprevention: current status and future prospects. Toxicol Appl Pharmacol 224: 369-376, 2007. (Pubitemid 47575668)
19. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR et al: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224: 274-283, 2007. (Pubitemid 47575677)
20. Wang W, Rayburn ER, Hao M, Zhao Y, Hill DL, Zhang R et al: Experimental therapy of prostate cancer with novel natural product anticancer ginsenosides. Prostate 68: 809-819, 2008. (Pubitemid 351845212)
21. Bandyopadhyay S, Romero JR and Chattopadhyay N: Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells. Mol Cell Endocrinol 287: 57-64, 2008.
22. Hafeez BB, Siddiqui IA, Asim M, Malik A, Afaq F, Adhami VM et al: A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-κB signaling. Cancer Res 68: 8564-8572, 2008.
23. Bosetti C, Bravi F, Talamini R, Parpinel M, Gnagnarella P, Negri E et al: Flavonoids and prostate cancer risk: a study in Italy. Nutr Cancer 56: 123-127, 2006. (Pubitemid 46417670)
24. Vayalil PK, Mittal A and Katiyar SK: Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NFκB. Carcinogenesis 25: 987-995, 2004. (Pubitemid 38906615)
25. Patel D, Shukla S and Gupta S: Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol 30: 233-245, 2007.
26. Boh B, Berovic M, Zhang J and Zhi-Bin L: Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 13: 265-301, 2007. (Pubitemid 47387127)
27. Petrylak DP: Future directions in the treatment of androgen-independent prostate cancer. Urology 65: 8-12, 2005. (Pubitemid 40804366)
28. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM and Lines TC: A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45: 2179-2205, 2007. (Pubitemid 47451573)
29. Bentivegna SS and Whitney KM: Subchronic 3-month oral toxicity study of grape seed and grape skin extracts. Food Chem Toxicol 40: 1731-1743, 2002. (Pubitemid 35284143)
30. Neuhouser ML: Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50: 1-7, 2004. (Pubitemid 39587599)
31. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M and Tsugane S: Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 167: 71-77, 2008.
32. Xiang YZ, Shang HC, Gao XM and Zhang BL: A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother Res 22: 851-858, 2008.
33. Yang, C. S, Sang, S, Lambert, J. D, Lee, M. J: Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 52(Suppl 1): S139-151, 2008.
34. Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA et al: Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 9: 3312-3319, 2003. (Pubitemid 37082725)
35. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr and Walle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32: 1377-1382, 2004. (Pubitemid 39564557)
36. Walle T, Wen X and Walle UK: Improving metabolic stability of cancer chemoprotective polyphenols. Expert Opin Drug Metab Toxicol 3: 379-388, 2007. (Pubitemid 47316030)
37. Scholz S and Williamson G: Interactions affecting the bioavailability of dietary polyphenols in vivo. Int J Vit Nutr Res 77: 224-235, 2007. (Pubitemid 47607432)
38. Wegiel B, Bjartell A, Tuomela J, Dizeyi N, Tinzl M, Helczynski L et al: Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis. J Natl Cancer Inst 100: 1022-1036, 2008. (Pubitemid 352019801)
39. Wegiel B, Bjartell A, Ekberg J, Gadaleanu V, Brunhoff C, Persson JL: A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer. Oncogene 24: 6385-6393, 2005. (Pubitemid 41486472)
40. Gupta S, Hussain T and Mukhtar H: Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410: 177-185, 2003. (Pubitemid 36268810)
41. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G and Corti A: Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66: 1234-1240, 2006. (Pubitemid 43165995)
42. Hung H: Bevacizumab plus 5-fluorouracil induce growth suppression in the CWR-22 and CWR-22R prostate cancer xenografts. Mol Cancer Ther 6: 2149-2157, 2007.
43. Yang CS, Lambert JD, Ju J, Lu G and Sang S: Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol 224: 265-273, 2007. (Pubitemid 47592860)
44. Gill C, Walsh SE, Morrissey C, Fitzpatrick JM and Watson RW: Resveratrol sensitizes androgen-independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 67: 1641-1653, 2007. (Pubitemid 350036950)
45. Knowles LM, Zigrossi DA, Tauber RA, Hightower C and Milner JA: Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer 38: 116-122, 2000. (Pubitemid 32377951)
46. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH and Im DS: Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 27: 429-435, 2004.
47. Liu WK, Xu SX and Che CT: Antiproliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci 67: 1297-1306, 2000.
48. Shukla S and Gupta S: Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study. Mol Carcinog 48: 243-252, 2008.